US 11000513
Anhydrous compositions of mTOR inhibitors and methods of use
granted A61KA61K31/436A61K31/5377
Quick answer
US patent 11000513 (Anhydrous compositions of mTOR inhibitors and methods of use) held by PALVELLA THERAPEUTICS, INC. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PALVELLA THERAPEUTICS, INC.
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/436, A61K31/5377, A61K45/06, A61K47/10